Metabolic genetic polymorphisms and susceptibility to lung cancer

被引：36

作者：

Bouchardy, C

Benhamou, S

Jourenkova, N

Dayer, P

Hirvonen, A

机构：

[1] Geneva Canc Registry, CH-1205 Geneva, Switzerland

[2] Inst Gustave Roussy, Canc Epidemiol Unit, INSERM U521, Villejuif, France

[3] Univ Hosp Geneva, Div Clin Pharmacol, Geneva, Switzerland

[4] Finnish Inst Occupat Hlth, Dept Ind Hyg & Toxicol, Helsinki, Finland

来源：

LUNG CANCER | 2001年 / 32卷 / 02期

关键词：

lung cancer; carcinogen; metabolism; enzyme; genotype; polymorphism; tobacco consumption; epidemiology;

D O I：

10.1016/S0169-5002(00)00215-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Activity of some enzymes implicated in the metabolism of tobacco carcinogens presents a great variability between individuals due to the existence of a polymorphism in gene coding for these enzymes. Individual susceptibility to develop lung cancer could therefore depend not only on exposure to tobacco smoking, but also on genetic capacity to activate or inactivate tobacco carcinogens. This article summarizes the state of knowledge on metabolic polymorphisms and lung cancer susceptibility, and opens the discussion on the future direction of this promising way of research. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.

引用

页码：109 / 112

页数：4

共 8 条

[1] [Anonymous], IARC SCI PUBLICATION
[2] Benhamou S, 1998, CANCER RES, V58, P5291
[3] CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian population
Bouchardy, C
Wikman, H
Benhamou, S
Hirvonen, A
Dayer, P
HusgafvelPursiainen, K
[J]. BIOMARKERS, 1997, 2 (02) : 131 - 134
[4] Bouchardy C, 1996, CANCER RES, V56, P251
[5] N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk
Bouchardy, C
Mitrunen, K
Wikman, H
Husgafvel-Pursiainen, K
Dayer, P
Benhamou, S
Hirvonen, A
[J]. PHARMACOGENETICS, 1998, 8 (04): : 291 - 298
[6] Effects of glutathione S-transferases GSTM1 and GSTT1 genotypes on lung cancer risk in smokers
Jourenkova, N
Reinikanen, M
Bouchardy, C
HusgafvelPursiainen, K
Dayer, P
Benhamou, S
Hirvonen, A
[J]. PHARMACOGENETICS, 1997, 7 (06): : 515 - 518
[7] Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer
Jourenkova-Mironova, N
Wikman, H
Bouchardy, C
Voho, A
Dayer, P
Benhamou, S
Hirvonen, A
[J]. PHARMACOGENETICS, 1998, 8 (06): : 495 - 502
[8] CYP2D6 ultrarapid metabolizer genotype as a potential modifier of smoking behaviour
Saarikoski, ST
Sata, F
Husgafvel-Pursiainen, K
Rautalahti, M
Haukka, J
Impivaara, O
Järvisalo, J
Vainio, H
Hirvonen, A
[J]. PHARMACOGENETICS, 2000, 10 (01): : 5 - 10

← 1 →